Skip to content

NEI Research News

Thanks to the work of NEI scientists and grantees, we’re constantly learning new information about the causes and treatment of vision disorders. Get the latest updates about their work — along with other news about NEI.

Source
851 items
empty

AI makes retinal imaging 100 times faster, compared to manual method

Researchers at the National Institutes of Health applied artificial intelligence (AI) to a technique that produces high-resolution images of cells in the eye. They report that with AI, imaging is 100 times faster and improves image contrast 3.5-fold.

Medical College of Georgia scientists establish protein database to advance vision research

Aqueous Humor Proteome Database includes comprehensive information on 1,683 proteins identified in aqeuous humor--the fluid in the eye's anterior chamber.
Optic nerve

Seeing a path to nerve regeneration

UConn scientists find protein that stimulates regrowth of optic nerve cells.
mosquito

Wayne State University researchers uncover potential treatment targets for Zika virus-related eye abnormalities

A groundbreaking study from Wayne State presents crucial insights into the ocular effects of Zika virus infection during pregnancy and offers promising avenues for therapeutic intervention.

NEI study points to ‘ground zero’ for AMD development

National Eye Institute researchers studying human retinas discovered 87 target genes where a mix of environmental factors likely influence one’s risk of developing age-related macular degeneration (AMD), a leading cause of vision loss.
People looking at the sky with eclipse glasses

How to watch an eclipse, safely

Keep your eyes safe when viewing the upcoming eclipse with these tips from the National Eye Institute.
minocycline pill bottle in front of retina photo

Inflammation-reducing drug shows no benefit for dry age-related macular degeneration in NIH trial

The drug minocycline, an antibiotic that also decreases inflammation, failed to slow vision loss or expansion of geographic atrophy in people with dry age-related macular degeneration (AMD), according to a phase II clinical study.
Contact lens with special edges on a person's eye.

Federal grants awarded to develop tech to monitor, treat chronic eye diseases

Purdue research teams will develop specialized smart soft contact lenses that continuously monitor or treat chronic ocular diseases like glaucoma, corneal neovascularization and dry eye syndromes.
Retinal cross section with photoreceptors and nuclei stained

ALG6 acts as a modifier gene in the inherited genetic eye disease retinitis pigmentosa 59

Variant of ALG6 delays rod photoreceptor degradation but decreases cone health in people with RP59 retinitis pigmentosa, according to a new study from University of Alabama, Birmingham.

'Monocyte factory' to help scientists study immune-related conditions of the eye

The technique, known by the research team as a “monocyte factory,” makes possible a theoretically limitless source of human immune cells for research and the development of therapies for a variety of conditions including eye disease.

Want more news from NEI?

Subscribe to our news feed to stay up to date on vision and eye health research!

Success! Link copied to clipboard.

Copy to clipboard failed.

You can also browse older stories in our news archive

NEI Press Office

We can connect media professionals with the latest vision research info. Get in touch!


Phone: 301-496-5248